Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Joshua Linscott

Has grant

Associate Member

H Lee Moffitt Cancer Center and Research Institute

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Biostatistics Biostatistics professors in United States

Recent Grants

Grant: Close

The Expanding Role of Urinary tumor DNA (utDNA) in Urothelial Carcinoma

Open Date: 2024-08-07

Close Date: 2024-08-09

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (2)

Brandon Manley

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES

View details

Roger Li

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joshua Linscott

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (13)

Short- and Intermediate-Term Morbidity Following Total Pelvic Exenteration in Colorectal Cancer.

MULTIPLEX IMMUNOFLUORESCENT PROFILING OF TERTIARY LYMPHOID STRUCTURES IN BCG TREATED NON-MUSCLE INVASIVE BLADDER CANCER

FGFR Inhibition in Urothelial Carcinoma

Letter: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

The Elusive Horizon: Biomarkers in Urothelial Carcinoma

MP22-19 POST-OPERATIVE ANTIBIOTIC PROPHYLAXIS IN RADICAL CYSTECTOMY PATIENTS REDUCES GU INFECTIONS

MP71-13 DELAYS IN INITIATING FIRST LINE BLADDER SPARING THERAPY PORTEND WORSE PROGRESSION-FREE SURVIVAL FOR BCG UNRESPONSIVE PATIENTS

PD48-03 DETECTING RESIDUAL TUMOR WITH CELL-FREE URINARY TUMOR DNA IN HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS

PD48-08 COMPARATIVE ANALYSIS OF METHYLATION BIOMARKERS IN TUMOR AND URINARY TUMOR DNA IN HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS

Editorial Comment

Tumor fraction and copy number burden from urinary cell-free tumor DNA (utDNA) to predict minimal residual disease prior to repeat-transurethral resection in high-risk non-muscle invasive bladder cancer (HR-NMIBC).

Distance to Treatment With Radical Cystectomy in a Rural State: Long Car Rides, Equivalent Outcomes

Prostate Specific Antigen Testing Behaviors for Prostate Cancer Screening Among US Immigrants: A Cross-sectional Analysis Using the National Health Interview Survey

Collaborators (2)

Brandon Manley

Roger Li

Make your next move.